Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease

Cited by (1,086)

Items 901–1,000 of 1,086

1. Habitual coffee consumption and risk of type 2 diabetes, ischemic heart disease, depression and Alzheimer’s disease: a Mendelian randomization study
   Man Ki Kwok, Gabriel Matthew Leung, Catherine Mary Schooling · 2016 · Scientific Reports
2. Genetic risk for schizophrenia and psychosis in Alzheimer disease
   Mary Ann A. DeMichele‐Sweet, Elise A. Weamer, Lambertus Klei, Dylan T. Vrana, Deborah J. Hollingshead, Howard J. Seltman, Rebecca Sims, Tatiana Foroud, Isabel Hernández, Sonia Moreno–Grau et al. · 2017 · Molecular Psychiatry
3. Body Mass Index and Risk of Alzheimer’s Disease: A Mendelian Randomization Study of 399,536 Individuals
   Liv Tybjærg Nordestgaard, Anne Tybjærg‐Hansen, Børge Grønne Nordestgaard, Ruth Frikke‐Schmidt · 2017 · The Journal of Clinical Endocrinology & Metabolism
4. Dysregulation of Rab5-Mediated Endocytic Pathways in Alzheimer’s Disease
   Wei Xu, Fang Fang, Jian-Qing Ding, Cheng-Biao Wu · 2018 · Traffic : the International Journal of Intracellular Transport
5. Meta-analysis of Alzheimer’s disease on 9,751 samples from Norway and IGAP study identifies four risk loci
   Aree Witoelar, Arvid Rongve, Ina S. Almdahl, Ingun Dina Ulstein, Andreas Engvig, Linda Rosemary White, Geir Selbæk, Eystein Stordal, Fred Andersen, Anne Brækhus et al. · 2018 · Scientific Reports
6. Cellular and Molecular Mediators of Neuroinflammation in Alzheimer Disease
   Seung‐Hoon Yang · 2019 · International Neurourology Journal
7. “Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease
   Chinthalapally V. Rao, Adam Steven Asch, Daniel J.J. Carr, Hiroshi Y. Yamada · 2020 · Aging Cell
8. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease
   DeMichele-Sweet, Mary Ann A., Klei, Lambertus, Creese, Byron, Harwood, Janet C., Weamer, Elise A., McClain, Lora, Sims, Rebecca, Hernandez, Isabel, Moreno-Grau, Sonia, Tárraga, Lluís et al. · 2021 · Molecular Psychiatry
9. Network Medicine for Alzheimer’s Disease and Traditional Chinese Medicine
   Juliet T. Jarrell, Li Gao, David S. Cohen, Xudong Huang · 2018 · Molecules
10. Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
    Pedrum Mohammadi‐Shemirani, Michael Chong, Marie Pigeyre, Robert W. Morton, Hertzel C. Gerstein, Guillaume Paré · 2020 · eLife
11. Socioeconomic Status Mediates Racial Differences Seen Using the AT(N) Framework
    Karin L. Meeker, Julie K. Wisch, Darrell Hudson, Dean W. Coble, Chengjie Xiong, Ganesh Muneshwar Babulal, Brian Andrew Gordon, Suzanne E. Schindler, Carlos Cruchaga, Shaney E. Flores et al. · 2020 · Annals of Neurology
12. MOSTWAS: Multi-Omic Strategies for Transcriptome-Wide Association Studies
    Arjun Bhattacharya, Yun Li, Michael I. Love · 2021 · PLoS Genetics
13. The genetic architecture of multimodal human brain age
    Junhao Wen, Bingxin Zhao, Zhijian Yang, Güray Erus, Ioanna Skampardoni, Elizabeth Mamourian, Yuhan Cui, Gyujoon Hwang, Jingxuan Bao, Aleix Boquet-Pujadas et al. · 2024 · Nature Communications
14. Gene-based aggregate SNP associations between candidate AD genes and cognitive decline
    Jasmine Nettiksimmons, Gregory J. Tranah, Daniel S. Evans, Jennifer S. Yokoyama, Kristine S. Yaffe · 2016 · AGE
15. Age-Related Differences in Brain Morphology and the Modifiers in Middle-Aged and Older Adults
    Lu Zhao, William J. Matloff, Kaida Ning, Hosung Kim, Ivo D. Dinov, Arthur W. Toga · 2018 · Cerebral Cortex
16. Prediction of clinical diagnosis of Alzheimer’s disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years
    Hannah R. Stocker, Laura Perna, Korbinian Weigl, Tobias Möllers, Ben Schöttker, Hauke Thomsen, Bernd Holleczek, Dan Rujescu, Hermann Brenner · 2020 · Molecular Psychiatry
17. Systematic review of strengths and limitations of Randomized Controlled Trials for non-pharmacological interventions in mild cognitive impairment: Focus on Alzheimer's disease
    Horr, T., Messinger-Rapport, B., Pillai, Jagan A. · 2015 · The Journal of nutrition, health and aging
18. Immune response and endocytosis pathways are associated with the resilience against Alzheimer’s disease
    Tesi, Niccolò, van der Lee, Sven J., Hulsman, Marc, Jansen, Iris E., Stringa, Najada, van Schoor, Natasja M., Scheltens, Philip, van der Flier, Wiesje M., Huisman, Martijn, Reinders, Marcel J. T. et al. · 2020 · Translational Psychiatry
19. The road ahead to cure Alzheimer’s disease: development of biological markers and neuroimaging methods for prevention trials across all stages and target populations
    Cavedo, E., Lista, S., Khachaturian, Z., Aisen, P., Amouyel, P., Herholz, K., Jack Jr, C.R., Sperling, R., Cummings, J., Blennow, K. et al. · 2014 · The Journal of Prevention of Alzheimer's Disease
20. Shared mechanisms among neurodegenerative diseases: from genetic factors to gene networks
    Douglas V. Arneson, Yong Zhang, Xia Yang, Manikandan Narayanan · 2018 · Journal of Genetics
21. ABCA7 and the altered lipidostasis hypothesis of Alzheimer's disease
    Nicholas N. Lyssenko, Domenico Praticò · 2020 · Alzheimer s & Dementia
22. Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults
    Byron Creese, Ryan Arathimos, Helen J. Brooker, Dag Aarsland, Anne Corbett, Cathryn M. Lewis, Clive G. Ballard, Zahinoor Ismail · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
23. Dissecting the complexities of Alzheimer disease with in vitro models of the human brain
    Joel Blanchard, Matheus B. Victor, Li‐Huei Tsai · 2021 · Nature Reviews Neurology
24. Mitochondrial Damage-Associated Molecular Patterns Content in Extracellular Vesicles Promotes Early Inflammation in Neurodegenerative Disorders
    Carla Lopes, Sandra Mota, Claudia Deus, Henrique Tavares, Margarida Beatriz · 2022 · Cells
25. Review: The genetics of A lzheimer's disease; putting flesh on the bones
    Christopher Medway, Kevin Morgan · 2013 · Neuropathology and Applied Neurobiology
26. Genetic Determinants of Disease Progression in Alzheimer's Disease
    Xingbin Wang, Oscar L. López, Robert A. Sweet, James T. Becker, Steven Trent DeKosky, M. Michael Barmada, F. Yesim Demirci, M. Ilyas Kamboh · 2014 · Journal of Alzheimer s Disease
27. Mitochondrial DNA haplogroup B5 confers genetic susceptibility to Alzheimer's disease in Han Chinese
    Rui Bi, Wen Zhang, Dandan Yu, Xiao Li, Hui-Zhen Wang, Qiu-Xiang Hu, Chen Zhang, Weihong Lu, Jianliang Ni, Yiru Fang et al. · 2014 · Neurobiology of Aging
28. esyN: Network Building, Sharing and Publishing
    Daniel M. Bean, Joshua Heimbach, Lorenzo Ficorella, Gos Micklem, Stephen G. Oliver, Giorgio Favrin · 2014 · PLoS ONE
29. An Alzheimer’s Disease Genetic Risk Score Predicts Longitudinal Thinning of Hippocampal Complex Subregions in Healthy Older Adults
    Theresa M. Harrison, Zanjbeel Mahmood, Edward P. Lau, Alexandra M. Karacozoff, Alison C. Burggren, Gary W. Small, Susan Y. Bookheimer · 2016 · eNeuro
30. Polygenic hazard scores in preclinical Alzheimer disease
    Chin Hong Tan, Bradley T. Hyman, Jacinth J. X. Tan, Christopher Paul Hess, William P. Dillon, Gerard D. Schellenberg, Lilah M. Besser, Walter A. Kukull, Karolina Kauppi, Linda K. McEvoy et al. · 2017 · Annals of Neurology
31. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease
    Kazuyuki Takata, Takahide Amamiya, Hiroaki Mizoguchi, Shohei Kawanishi, Eriko Kuroda, Risa Kitamura, Aina Ito, Yuki Saito, Manami Tawa, Tomofumi Nagasawa et al. · 2017 · Neurobiology of Aging
32. Association of Alzheimer's genetic loci with mild behavioral impairment
    Shea J. Andrews, Zahinoor Ismail, Kaarin Jane Anstey, Moyra E. Mortby · 2018 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
33. Shared genetic architecture between metabolic traits and Alzheimer’s disease: a large-scale genome-wide cross-trait analysis
    Zhaozhong Zhu, Yifei Lin, Xihao Li, Jane Ann Driver, Liming Liang · 2019 · Human Genetics
34. Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer’s Disease
    Adorni, Maria Pia, Ruscica, Massimiliano, Ferri, Nicola, Bernini, Franco, Zimetti, Francesca · 2019 · Frontiers in Aging Neuroscience
35. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale
    Nicolas Ruffini, Susanne Klingenberg, Susann Schweiger, Susanne Gerber · 2020 · Cells
36. Cilia interactome with predicted protein-protein interactions reveals connections to Alzheimer’s disease, aging and other neuropsychiatric processes
    Karunakaran, Kalyani B., Chaparala, Srilakshmi, Lo, Cecilia W., Ganapathiraju, Madhavi K. · 2020 · Scientific Reports
37. A transcriptome-wide association study based on 27 tissues identifies 106 genes potentially relevant for disease pathology in age-related macular degeneration
    Strunz, Tobias, Lauwen, Susette, Kiel, Christina, International AMD Genomics Consortium (IAMDGC), Fritsche, Lars G., Igl, Wilmar, Bailey, Jessica N. Cooke, Grassmann, Felix, Sengupta, Sebanti, Bragg-Gresham, Jennifer L. et al. · 2020 · Scientific Reports
38. Brain-specific functional relationship networks inform autism spectrum disorder gene prediction
    Marlena Duda, Hongjiu Zhang, Hong‐Dong Li, Dennis Paul Wall, Margit Burmeister, Yuanfang Guan · 2018 · Translational Psychiatry
39. Association of Rare Coding Mutations With Alzheimer Disease and Other Dementias Among Adults of European Ancestry
    Devanshi Patel, Jesse B Mez, Badri Narayan Vardarajan, Lyndsay A. Staley, Jaeyoon Chung, Xiaoling Zhang, John J. Farrell, Michael J. Rynkiewicz, Lisa Cannon‐Albright, Craig Carl Teerlink et al. · 2019 · JAMA Network Open
40. Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study
    Gina Marie Peloso, Alexa Beiser, Claudia Liliana Satizábal, Vanessa Xanthakis, Ramachandran Srini Vasan, Matthew Paul Pase, Anita L. DeStefano, Sudha S. Seshadri · 2020 · Neurology
41. The Alzheimer susceptibility gene BIN1 induces isoform-dependent neurotoxicity through early endosome defects
    Erwan Lambert, Orthis Saha, Bruna Soares Landeira, Ana Raquel Melo de Farias, Xavier Hermant, Arnaud Carrier, Alexandre Pelletier, Johanna Gadaut, Lindsay Davoine, Cloé Dupont et al. · 2022 · Acta Neuropathologica Communications
42. Alzheimer Disease and Epilepsy
    Yi Fang, Xiaoli Si, Jiali Wang, Zhiyun Wang, Ying Chen, Yi Liu, Yaping Yan, Jun Tian, Baorong Zhang, Jiali Pu · 2023 · Neurology
43. Extracellular vesicles from human‐induced pluripotent stem cell‐derived neural stem cells alleviate proinflammatory cascades within disease‐associated microglia in Alzheimer's disease
    Leelavathi Narayana Madhu, Maheedhar Kodali, Raghavendra Upadhya, Shama Rao, Yogish Somayaji, Sahithi Attaluri, Bing Shuai, Maha Kirmani, Shreyan Gupta, Nathaniel Maness et al. · 2024 · Journal of Extracellular Vesicles
44. On the central role of brain connectivity in neurodegenerative disease progression
    Yasser Iturria‐Medina, Alan Charles Evans · 2015 · Frontiers in Aging Neuroscience
45. Epidemiology of dementia in Central Africa (EPIDEMCA): protocol for a multicentre population-based study in rural and urban areas of the Central African Republic and the Republic of Congo
    the EPIDEMCA group, Maëlenn Guerchet, Pascal Mbélesso, Bebene Ndamba Bandzouzi, Sophie Pilleron, Ileana Désormais, Philippe Lacroix, Victor Aboyans, Pierre Jésus, Jean‐Claude Desport et al. · 2014 · SpringerPlus
46. Investigating the role of rare coding variability in Mendelian dementia genes ( APP , PSEN1 , PSEN2 , GRN , MAPT , and PRNP ) in late-onset Alzheimer's disease
    Celeste Sassi, Rita João Guerreiro, Jesse Raphael Gibbs, Jinhui Ding, Michelle K. Lupton, Claire Troakes, Safa Al‐Sarraj, Michael Niblock, Jean‐Marc Gallo, Jihad Adnan et al. · 2014 · Neurobiology of Aging
47. Genetics of Alzheimer's Disease
    Jong Hun Kim · 2018 · Dementia and Neurocognitive Disorders
48. Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer’s disease
    Jin Xu, Giulia Bankov, Min Gyu Kim, Asger Wretlind, Jodie Lord, Rebecca Green, Angela Hodges, Abdul Hye, Dag Aarsland, Latha Velayudhan et al. · 2020 · Translational Neurodegeneration
49. Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease
    Mark L. Cohen, Brian Stephen Appleby, Jiri Safar · 2016 · Prion
50. Centenarian controls increase variant effect sizes by an average twofold in an extreme case–extreme control analysis of Alzheimer’s disease
    Tesi, Niccolò, van der Lee, Sven J., Hulsman, Marc, Jansen, Iris E., Stringa, Najada, van Schoor, Natasja, Meijers-Heijboer, Hanne, Huisman, Martijn, Scheltens, Philip, Reinders, Marcel J. T. et al. · 2019 · European Journal of Human Genetics
51. An integrative tissue-network approach to identify and test human disease genes
    Vicky Yao, Rachel L. Kaletsky, William D. Keyes, Danielle E. Mor, Aaron K. Wong, Salman Sohrabi, Coleen Tara Murphy, Olga G. Troyanskaya · 2018 · Nature Biotechnology
52. Transcriptional regulation of homeostatic and disease‐associated‐microglial genes by IRF1, LXRβ, and CEBPα
    Tianwen Gao, Janna E. Jernigan, Syed Ali Raza, Eric B. Dammer, Hailian Xiao, Nicholas T. Seyfried, Allan I. Levey, Srikant Rangaraju · 2019 · Glia
53. Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer’s Disease
    Catarina Perdigão, Mariana A. Barata, Margarida N. Araújo, F. Mirfakhar, Jorge Castanheira, Cláudia Guimas Almeida · 2020 · Frontiers in Cellular Neuroscience
54. Reactive or transgenic increase in microglial TYROBP reveals a TREM2‐independent TYROBP–APOE link in wild‐type and Alzheimer's‐related mice
    Audrain, Mickael, Haure‐Mirande, Jean‐Vianney, Mleczko, Justyna, Wang, Minghui, Griffin, Jennifer K., St George‐Hyslop, Peter H., Fraser, Paul, Zhang, Bin, Gandy, Sam, Ehrlich, Michelle E. · 2021 · Alzheimer's & Dementia
55. Differentially expressed genes in Alzheimer’s disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1
    Qingqin S. Li, Louis De Muynck · 2021 · Brain Behavior & Immunity - Health
56. Expression quantitative trait loci (eQTLs) in human placentas suggest developmental origins of complex diseases
    Shouneng Peng, Maya A. Deyssenroth, Antonio Fabio Di Narzo, Luca Lambertini, Carmen J. Marsit, Jia Chen, Ke Hao · 2017 · Human Molecular Genetics
57. Genetic effects on promoter usage are highly context-specific and contribute to complex traits
    Kaur Alasoo, Julia Rodrigues, John Danesh, Daniel F. Freitag, Dirk S. Paul, Daniel J. Gaffney · 2019 · eLife
58. A comprehensive analysis of methods for assessing polygenic burden on Alzheimer’s disease pathology and risk beyond APOE
    Altmann, Andre, Scelsi, Marzia A, Shoai, Maryam, de Silva, Eric, Aksman, Leon M, Cash, David M, Hardy, John, Schott, Jonathan M, Alzheimer’s Disease Neuroimaging Initiative · 2020 · Brain Communications
59. Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer’s Disease
    Cátia S. Janota, Cynthia Ann Lemere, María Alexandra Brito · 2015 · Molecular Neurobiology
60. A candidate regulatory variant at the <i>TREM</i> gene cluster associates with decreased Alzheimer's disease risk and increased <i>TREML1</i> and <i>TREM2</i> brain gene expression
    Carrasquillo, Minerva M., Allen, Mariet, Burgess, Jeremy D., Wang, Xue, Strickland, Samantha L., Aryal, Shivani, Siuda, Joanna, Kachadoorian, Michaela L., Medway, Christopher, Younkin, Curtis S. et al. · 2017 · Alzheimer's &amp; Dementia
61. Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
    Brown, Madeleine R., Radford, Sheena E., Hewitt, Eric W. · 2020 · Frontiers in Molecular Neuroscience
62. <i>APOE</i> and dementia – resequencing and genotyping in 105,597 individuals
    Rasmussen, Katrine L., Tybjærg‐Hansen, Anne, Nordestgaard, Børge G., Frikke‐Schmidt, Ruth · 2020 · Alzheimer's &amp; Dementia
63. PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease
    Giralt, Albert, de Pins, Benoit, Cifuentes-Díaz, Carmen, López-Molina, Laura, Farah, Amel Thamila, Tible, Marion, Deramecourt, Vincent, Arold, Stefan T, Ginés, Silvia, Hugon, Jacques et al. · 2018 · Experimental Neurology
64. Molecular estimation of neurodegeneration pseudotime in older brains
    Sumit Mukherjee, Laura M. Heath, Christoph Preuß, Suman Jayadev, Gwenn A. Garden, Anna K. Greenwood, Solveig K. Sieberts, Philip L. De Jager, Nilüfer Ertekin‐Taner, Gregory W. Carter et al. · 2020 · Nature Communications
65. PET imaging of colony-stimulating factor 1 receptor: A head-to-head comparison of a novel radioligand, 11 C-GW2580, and 11 C-CPPC, in mouse models of acute and chronic neuroinflammation and a rhesus monkey
    Xiaoyun Zhou, Bin Ji, Chie Seki, Yuji Nagai, Takafumi Minamimoto, Masayuki Fujinaga, Ming‐Rong Zhang, Takashi Saito, Takaomi C. Saido, Tetsuya Suhara et al. · 2021 · Journal of Cerebral Blood Flow & Metabolism
66. Reassessment of Pioglitazone for Alzheimer’s Disease
    Ann M. Saunders, Daniel K. Burns, William Kirby Gottschalk · 2021 · Frontiers in Neuroscience
67. The Role of Astrocytes in Synapse Loss in Alzheimer's Disease: A Systematic Review
    Lianne A. Hulshof, Danny van Nuijs, Elly M. Hol, Jinte Middeldorp · 2022 · Frontiers in Cellular Neuroscience
68. Roles of Non-Coding RNA in Alzheimer’s Disease Pathophysiology
    Edward O. Olufunmilayo, R. M. Damian Holsinger · 2023 · International Journal of Molecular Sciences
69. Genetic modifiers of Mendelian disease: Huntington’s disease and the trinucleotide repeat disorders
    Peter Holmans, Thomas H. Massey, Lesley Jones · 2017 · Human Molecular Genetics
70. The effects of the TOMM40 poly‐T alleles on Alzheimer's disease phenotypes
    Ornit Chiba‐Falek, William Kirby Gottschalk, Michael William Lutz · 2018 · Alzheimer s & Dementia
71. Genome-Scale Transcriptional Regulatory Network Models of Psychiatric and Neurodegenerative Disorders
    Jocelynn R. Pearl, Carlo Colantuoni, Dani E. Bergey, Cory C. Funk, Paul T. Shannon, Bijoya Basu, Alex M. Casella, Rediet T. Oshone, Leroy Hood, Nathan D. Price et al. · 2019 · Cell Systems
72. Dementia.
    Emma Louise Cunningham, Bernadette McGuinness, Brian M. Herron, Anthony Peter Passmore · 2015 · PubMed Central
73. PLD3 gene variants and Alzheimer's disease
    Basavaraj V. Hooli, Christina M. Lill, Kristina Mullin, Dandi Qiao, Christoph Lange, Lars Bertram, Rudolph E. Tanzi · 2015 · Nature
74. Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways
    Christopher Böhm, F. Chen, Jean Sévalle, Seema Qamar, Roger B. Dodd, Y. Li, Gerold Schmitt‐Ulms, Paul E. Fraser, Peter St George‐Hyslop · 2015 · Molecular and Cellular Neuroscience
75. Accelerated MRI-predicted brain ageing and its associations with cardiometabolic and brain disorders
    Arinbjörn Kolbeinsson, Sarah L. Filippi, Yannis Panagakis, Paul McMahan Matthews, Paul Elliott, Abbas Dehghan, Ioanna Tzoulaki · 2020 · Scientific Reports
76. Novel Variance-Component TWAS method for studying complex human diseases with applications to Alzheimer’s dementia
    Shizhen Tang, Aron S. Buchman, Philip L. De Jager, David Alan Bennett, Michael P. Epstein, Jingjing Yang · 2021 · PLoS Genetics
77. Multi-tissue neocortical transcriptome-wide association study implicates 8 genes across 6 genomic loci in Alzheimer’s disease
    Jake Gockley, Kelsey S. Montgomery, William L. Poehlman, Jesse C. Wiley, Yue Liu, Ekaterina Sergeevna Gerasimov, Anna K. Greenwood, Solveig K. Sieberts, Aliza P. Wingo, Thomas S. Wingo et al. · 2021 · Genome Medicine
78. A review on omics-based biomarkers discovery for Alzheimer's disease from the bioinformatics perspectives: Statistical approach vs machine learning approach
    Mei Sze Tan, Phaik‐Leng Cheah, Ai‐Vyrn Chin, Lai‐Meng Looi, Siow‐Wee Chang · 2021 · Computers in Biology and Medicine
79. Sorting receptor SORLA: cellular mechanisms and implications for disease
    Schmidt, Vanessa, Subkhangulova, Aygul, Willnow, Thomas E. · 2017 · Cellular and Molecular Life Sciences
80. Polygenic risk scores in familial Alzheimer disease
    Giuseppe Tosto, Thomas D. Bird, Debby W. Tsuang, David Bennett, Bradley F. Boeve, Carlos Cruchaga, Kelley M. Faber, Tatiana Foroud, Martin Rhys Farlow, Alison Goate et al. · 2017 · Neurology
81. Alzheimer’s disease and the autophagic-lysosomal system
    Chung, Kyung Min, Hernández, Nancy, Sproul, Andrew A., Yu, Wai Haung · 2019 · Neuroscience Letters
82. Transcriptomic and genetic analyses reveal potential causal drivers for intractable partial epilepsy
    Sebastian Guelfi, Juan Antonio Botía, Maria Thom, Adaikalavan Ramasamy, Marina Perona, Lee Stanyer, Lillian Martinian, Daniah Trabzuni, Colin Smith, ROBERT E. WALKER et al. · 2019 · Brain
83. Amyloid-β: A double agent in Alzheimer's disease?
    Yu, Hao, Wu, Jie · 2021 · Biomedicine &amp; Pharmacotherapy
84. Effects of APOE Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease
    Dai, Jingting, Johnson, Erik C. B., Dammer, Eric B., Duong, Duc M., Gearing, Marla, Lah, James J., Levey, Allan I., Wingo, Thomas S., Seyfried, Nicholas T. · 2018 · Frontiers in Molecular Neuroscience
85. Combining Polygenic Hazard Score With Volumetric MRI and Cognitive Measures Improves Prediction of Progression From Mild Cognitive Impairment to Alzheimer's Disease
    Kauppi, Karolina, Fan, Chun Chieh, McEvoy, Linda K., Holland, Dominic, Tan, Chin Hong, Chen, Chi-Hua, Andreassen, Ole A., Desikan, Rahul S., Dale, Anders M., The Alzheimer's Disease Neuroimaging Initiative · 2018 · Frontiers in Neuroscience
86. African ancestry GWAS of dementia in a large military cohort identifies significant risk loci
    Sherva, Richard, Zhang, Rui, Sahelijo, Nathan, Jun, Gyungah, Anglin, Tori, Chanfreau, Catherine, Cho, Kelly, Fonda, Jennifer R., Gaziano, J. Michael, Harrington, Kelly M. et al. · 2023 · Molecular Psychiatry
87. Genetically Determined Uric Acid and the Risk of Cardiovascular and Neurovascular Diseases: A Mendelian Randomization Study of Outcomes Investigated in Randomized Trials
    Anthoula Efstathiadou, Dipender Gill, Frances McGrane, Terence J. Quinn, Jesse Dawson · 2019 · Journal of the American Heart Association
88. Microglial Function and Regulation during Development, Homeostasis and Alzheimer’s Disease
    Brad T. Casali, Erin G. Reed-Geaghan · 2021 · Cells
89. The small HDL particle hypothesis of Alzheimer's disease
    Ashley E. Martinez, Gali H. Weissberger, Zsuzsanna Kuklenyik, Xulei He, Cristiana Joy Meuret, Trusha Parekh, Jon C. Rees, Bryan A. Parks, Michael S. Gardner, Sarah M. King et al. · 2022 · Alzheimer s & Dementia
90. Predicting long-term progression of Alzheimer’s disease using a multimodal deep learning model incorporating interaction effects
    Yifan Wang, Ruitian Gao, Ting Wei, Luke J. Johnston, Xin Yuan, Yue Zhang, Zhangsheng Yu, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Journal of Translational Medicine
91. New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer’s disease
    Yuan Cao, Linwei Zhao, Zi Chen, Shaohua Li · 2024 · Frontiers in Neuroscience
92. A meta-analysis of heritability of cognitive aging: minding the “missing heritability” gap
    C. Reynolds, Deborah Finkel · 2015 · Neuropsychology Review
93. Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population
    Qianyi Xiao, Zhi-Jun Liu, Shasha Tao, Yi-Min Sun, Deke Jiang, Honglei Li, Haitao Chen, Xu Liu, Brittany R. Lapin, Chi‐Hsiung Wang et al. · 2015 · Oncotarget
94. The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease
    Giuseppe Tosto, Thomas D. Bird, David Alan Bennett, Bradley F. Boeve, Adam M. Brickman, Carlos Cruchaga, Kelley M. Faber, Tatiana Foroud, Martin Rhys Farlow, Alison Goate et al. · 2016 · JAMA Neurology
95. Complement Biomarkers as Predictors of Disease Progression in Alzheimer’s Disease
    Svetlana Hakobyan, Katharine Elizabeth Harding, Mohammed Aiyaz, Abdul Hye, Richard Dobson, Alison L. Baird, Benjamine Liu, Claire Louise Harris, Simon Lovestone, B. Paul Morgan · 2016 · Journal of Alzheimer s Disease
96. Clinical Amyloid Imaging
    Atul K. Mallik, Alexander E. Drzezga, Satoshi Minoshima · 2016 · Seminars in Nuclear Medicine
97. Early-Onset Alzheimer Disease and Candidate Risk Genes Involved in Endolysosomal Transport
    Brian W. Kunkle, Badri Narayan Vardarajan, Adam Christian Naj, Patrice L. Whitehead, Sophie Rolati, Susan Slifer, Regina M. Carney, Michael L. Cuccaro, Jeffery M. Vance, John R. Gilbert et al. · 2017 · JAMA Neurology
98. Rose Essential Oil Delayed Alzheimer’s Disease-Like Symptoms by SKN-1 Pathway in C. elegans
    Shuqian Zhu, Hongyu Li, Juan Dong, Wenqi Yang, Ting Liu, Yu Wang, Xin Wang, Meizhu Wang, Dejuan Zhi · 2017 · Journal of Agricultural and Food Chemistry
99. Circulating vitamin E levels and Alzheimer's disease: a Mendelian randomization study
    Guiyou Liu, Yi Zhao, Shuilin Jin, Yang Hu, Tao Wang, Rui Tian, Zhifa Han, Dandan Xu, Qinghua Jiang · 2018 · Neurobiology of Aging
100. A Prospective Analysis of Genetic Variants Associated with Human Lifespan
     Kevin M. Wright, Kristin A. Rand, Amir R. Kermany, Keith Noto, Don Curtis, Daniel Garrigan, Dmitri Slinkov, Ilya Dorfman, Julie M. Granka, Jake Byrnes et al. · 2019 · G3 Genes Genomes Genetics